Zdrowie i gospodarka · 18/01/2017
FDA Announces Draft Guidance for Demonstrating Interchangeability of Therapeutic Protein Products
The FDA has released a draft guidance to help pharmaceutical companies prove that their proposed protein-based treatments are interchangeable with existing reference products, a key step in securing FDA approval.
Source: Federal Register — Food and Drug AdministrationOpen original release →